Table 2.

Relative contribution (%) of all possible antigen combinations to MATS-predicted coverage in three countries [5, 30, 32, 33].

Antigen (MATS phenotype)	England and Wales (n = 535)	Canada (n = 157)	Greece (n = 148)
fHbp+/NHBA−/NadA−/PorA−	14.6	12.7	9.5
fHbp−/NHBA+/NadA−/PorA−	7.9	13.4	33.8
fHbp−/NHBA−/NadA+/PorA−	—	—	0.7
fHbp−/NHBA−/NadA−/PorA+	0.4	—	0.7
fHbp+/NHBA+/NadA−/PorA−	29.9	25.5	37.1
fHbp+/NHBA−/NadA+/PorA−	—	0.6	—
fHbp+/NHBA−/NadA−/PorA+	3.2	1.9	—
fHbp−/NHBA+/NadA−/PorA+	0.9	—	1.3
fHbp−/NHBA+/NadA+/PorA−	0.4	0.6	—
fHbp−/NHBA−/NadA+/PorA+	—	—	—
fHbp+/NHBA+/NadA+/PorA−	0.2	—	—
fHbp+/NHBA+/NadA−/PorA+	15.7	11.5	6.1
fHbp+/NHBA−/NadA+/PorA+	—	—	—
fHbp−/NHBA+/NadA+/PorA+	—	—	—
fHbp+/NHBA+/NadA+/PorA+	—	—	—
fHbp−/NHBA−/NadA−/PorA−	26.9	33.8	10.8